The human papillomavirus (HPV)-related cancer biology: An overview

•Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are man...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2018-10, Vol.106, p.1537-1556
Hauptverfasser: Araldi, Rodrigo Pinheiro, Sant’Ana, Thalita Araujo, Módolo, Diego Grando, de Melo, Thatiana Correa, Spadacci-Morena, Diva Denelle, de Cassia Stocco, Rita, Cerutti, Janete Maria, de Souza, Edislane Barreiros
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1556
container_issue
container_start_page 1537
container_title Biomedicine & pharmacotherapy
container_volume 106
creator Araldi, Rodrigo Pinheiro
Sant’Ana, Thalita Araujo
Módolo, Diego Grando
de Melo, Thatiana Correa
Spadacci-Morena, Diva Denelle
de Cassia Stocco, Rita
Cerutti, Janete Maria
de Souza, Edislane Barreiros
description •Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are mandatory. Despite the novel diagnostic methods and therapies implemented in oncology, the number of patients that succumb by the cancer remains high globally. Currently studies point out that 20–25% of all human malignancies are related to micro-organism infections. Among these cancer-related pathogens, the human papillomavirus (HPV) has a prominent position, since the virus is responsible for about 30% of all infectious agent-related cancers. Thus, an amount of cancers could be avoided by means prophylactic and/or therapeutic measures. However, these measures required a holistic comprehension about HPV-related cancer biology. Based on this, this review aims to summarize the last evidences of HPV on cancer biology (from initiation to metastasis), focus on molecular and biochemical deregulations associated with viral infection, and discuss the viral etiology in different malignancies.
doi_str_mv 10.1016/j.biopha.2018.06.149
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2089856478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332218328178</els_id><sourcerecordid>2089856478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-488206ccaf8855eab0dc292468ce78b4c98b1cdcc7bdf8799b6fa44d82605e473</originalsourceid><addsrcrecordid>eNp9kD1PwzAURS0EgvLxDxDKWIaEZ8dxbAakgoAiVYKhsFqO80JdJU2wm6L-e4IKjExvOfdd3UPIOYWEAhVXy6RwbbcwCQMqExAJ5WqPjKjKIBYA-T4ZQZ6lcZoydkSOQ1gCQCZSeUiOUqBUMaZG5Ha-wGjRN2YVdaZzdd02ZuN8H6Lx9OXtMvZYmzWWkTUriz4aKuv2fXsdTVZRu0G_cfh5Sg4qUwc8-7kn5PXhfn43jWfPj093k1lsOch1zKVkIKw1lZRZhqaA0jLFuJAWc1lwq2RBbWltXpSVzJUqRGU4LyUTkCHP0xMy3v3tfPvRY1jrxgWLdW1W2PZBM5BKZoLnckD5DrW-DcFjpTvvGuO3moL-tqeXemdPf9vTIPRgb4hd_DT0RYPlX-hX1wDc7AAcdg7bvQ7W4WCmdB7tWpet-7_hCzvPgcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2089856478</pqid></control><display><type>article</type><title>The human papillomavirus (HPV)-related cancer biology: An overview</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Araldi, Rodrigo Pinheiro ; Sant’Ana, Thalita Araujo ; Módolo, Diego Grando ; de Melo, Thatiana Correa ; Spadacci-Morena, Diva Denelle ; de Cassia Stocco, Rita ; Cerutti, Janete Maria ; de Souza, Edislane Barreiros</creator><creatorcontrib>Araldi, Rodrigo Pinheiro ; Sant’Ana, Thalita Araujo ; Módolo, Diego Grando ; de Melo, Thatiana Correa ; Spadacci-Morena, Diva Denelle ; de Cassia Stocco, Rita ; Cerutti, Janete Maria ; de Souza, Edislane Barreiros</creatorcontrib><description>•Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are mandatory. Despite the novel diagnostic methods and therapies implemented in oncology, the number of patients that succumb by the cancer remains high globally. Currently studies point out that 20–25% of all human malignancies are related to micro-organism infections. Among these cancer-related pathogens, the human papillomavirus (HPV) has a prominent position, since the virus is responsible for about 30% of all infectious agent-related cancers. Thus, an amount of cancers could be avoided by means prophylactic and/or therapeutic measures. However, these measures required a holistic comprehension about HPV-related cancer biology. Based on this, this review aims to summarize the last evidences of HPV on cancer biology (from initiation to metastasis), focus on molecular and biochemical deregulations associated with viral infection, and discuss the viral etiology in different malignancies.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2018.06.149</identifier><identifier>PMID: 30119229</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Cancer progression ; Cancer Vaccines - administration &amp; dosage ; Cell Transformation, Viral ; Genotype ; Host-Pathogen Interactions ; HPV ; Humans ; Metastasis ; Mutation ; Neoplasms - metabolism ; Neoplasms - pathology ; Neoplasms - prevention &amp; control ; Neoplasms - virology ; Oncogene Proteins, Viral - metabolism ; Oncology ; Papillomaviridae - genetics ; Papillomaviridae - metabolism ; Papillomaviridae - pathogenicity ; Papillomavirus Infections - metabolism ; Papillomavirus Infections - pathology ; Papillomavirus Infections - prevention &amp; control ; Papillomavirus Infections - virology ; Papillomavirus Vaccines - administration &amp; dosage ; Phenotype ; Prognosis ; Risk Factors</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2018-10, Vol.106, p.1537-1556</ispartof><rights>2018</rights><rights>Copyright © 2018. Published by Elsevier Masson SAS.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-488206ccaf8855eab0dc292468ce78b4c98b1cdcc7bdf8799b6fa44d82605e473</citedby><cites>FETCH-LOGICAL-c408t-488206ccaf8855eab0dc292468ce78b4c98b1cdcc7bdf8799b6fa44d82605e473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0753332218328178$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30119229$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Araldi, Rodrigo Pinheiro</creatorcontrib><creatorcontrib>Sant’Ana, Thalita Araujo</creatorcontrib><creatorcontrib>Módolo, Diego Grando</creatorcontrib><creatorcontrib>de Melo, Thatiana Correa</creatorcontrib><creatorcontrib>Spadacci-Morena, Diva Denelle</creatorcontrib><creatorcontrib>de Cassia Stocco, Rita</creatorcontrib><creatorcontrib>Cerutti, Janete Maria</creatorcontrib><creatorcontrib>de Souza, Edislane Barreiros</creatorcontrib><title>The human papillomavirus (HPV)-related cancer biology: An overview</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>•Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are mandatory. Despite the novel diagnostic methods and therapies implemented in oncology, the number of patients that succumb by the cancer remains high globally. Currently studies point out that 20–25% of all human malignancies are related to micro-organism infections. Among these cancer-related pathogens, the human papillomavirus (HPV) has a prominent position, since the virus is responsible for about 30% of all infectious agent-related cancers. Thus, an amount of cancers could be avoided by means prophylactic and/or therapeutic measures. However, these measures required a holistic comprehension about HPV-related cancer biology. Based on this, this review aims to summarize the last evidences of HPV on cancer biology (from initiation to metastasis), focus on molecular and biochemical deregulations associated with viral infection, and discuss the viral etiology in different malignancies.</description><subject>Animals</subject><subject>Cancer progression</subject><subject>Cancer Vaccines - administration &amp; dosage</subject><subject>Cell Transformation, Viral</subject><subject>Genotype</subject><subject>Host-Pathogen Interactions</subject><subject>HPV</subject><subject>Humans</subject><subject>Metastasis</subject><subject>Mutation</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Neoplasms - prevention &amp; control</subject><subject>Neoplasms - virology</subject><subject>Oncogene Proteins, Viral - metabolism</subject><subject>Oncology</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomaviridae - metabolism</subject><subject>Papillomaviridae - pathogenicity</subject><subject>Papillomavirus Infections - metabolism</subject><subject>Papillomavirus Infections - pathology</subject><subject>Papillomavirus Infections - prevention &amp; control</subject><subject>Papillomavirus Infections - virology</subject><subject>Papillomavirus Vaccines - administration &amp; dosage</subject><subject>Phenotype</subject><subject>Prognosis</subject><subject>Risk Factors</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAURS0EgvLxDxDKWIaEZ8dxbAakgoAiVYKhsFqO80JdJU2wm6L-e4IKjExvOfdd3UPIOYWEAhVXy6RwbbcwCQMqExAJ5WqPjKjKIBYA-T4ZQZ6lcZoydkSOQ1gCQCZSeUiOUqBUMaZG5Ha-wGjRN2YVdaZzdd02ZuN8H6Lx9OXtMvZYmzWWkTUriz4aKuv2fXsdTVZRu0G_cfh5Sg4qUwc8-7kn5PXhfn43jWfPj093k1lsOch1zKVkIKw1lZRZhqaA0jLFuJAWc1lwq2RBbWltXpSVzJUqRGU4LyUTkCHP0xMy3v3tfPvRY1jrxgWLdW1W2PZBM5BKZoLnckD5DrW-DcFjpTvvGuO3moL-tqeXemdPf9vTIPRgb4hd_DT0RYPlX-hX1wDc7AAcdg7bvQ7W4WCmdB7tWpet-7_hCzvPgcQ</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Araldi, Rodrigo Pinheiro</creator><creator>Sant’Ana, Thalita Araujo</creator><creator>Módolo, Diego Grando</creator><creator>de Melo, Thatiana Correa</creator><creator>Spadacci-Morena, Diva Denelle</creator><creator>de Cassia Stocco, Rita</creator><creator>Cerutti, Janete Maria</creator><creator>de Souza, Edislane Barreiros</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201810</creationdate><title>The human papillomavirus (HPV)-related cancer biology: An overview</title><author>Araldi, Rodrigo Pinheiro ; Sant’Ana, Thalita Araujo ; Módolo, Diego Grando ; de Melo, Thatiana Correa ; Spadacci-Morena, Diva Denelle ; de Cassia Stocco, Rita ; Cerutti, Janete Maria ; de Souza, Edislane Barreiros</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-488206ccaf8855eab0dc292468ce78b4c98b1cdcc7bdf8799b6fa44d82605e473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Cancer progression</topic><topic>Cancer Vaccines - administration &amp; dosage</topic><topic>Cell Transformation, Viral</topic><topic>Genotype</topic><topic>Host-Pathogen Interactions</topic><topic>HPV</topic><topic>Humans</topic><topic>Metastasis</topic><topic>Mutation</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Neoplasms - prevention &amp; control</topic><topic>Neoplasms - virology</topic><topic>Oncogene Proteins, Viral - metabolism</topic><topic>Oncology</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomaviridae - metabolism</topic><topic>Papillomaviridae - pathogenicity</topic><topic>Papillomavirus Infections - metabolism</topic><topic>Papillomavirus Infections - pathology</topic><topic>Papillomavirus Infections - prevention &amp; control</topic><topic>Papillomavirus Infections - virology</topic><topic>Papillomavirus Vaccines - administration &amp; dosage</topic><topic>Phenotype</topic><topic>Prognosis</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Araldi, Rodrigo Pinheiro</creatorcontrib><creatorcontrib>Sant’Ana, Thalita Araujo</creatorcontrib><creatorcontrib>Módolo, Diego Grando</creatorcontrib><creatorcontrib>de Melo, Thatiana Correa</creatorcontrib><creatorcontrib>Spadacci-Morena, Diva Denelle</creatorcontrib><creatorcontrib>de Cassia Stocco, Rita</creatorcontrib><creatorcontrib>Cerutti, Janete Maria</creatorcontrib><creatorcontrib>de Souza, Edislane Barreiros</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Araldi, Rodrigo Pinheiro</au><au>Sant’Ana, Thalita Araujo</au><au>Módolo, Diego Grando</au><au>de Melo, Thatiana Correa</au><au>Spadacci-Morena, Diva Denelle</au><au>de Cassia Stocco, Rita</au><au>Cerutti, Janete Maria</au><au>de Souza, Edislane Barreiros</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The human papillomavirus (HPV)-related cancer biology: An overview</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2018-10</date><risdate>2018</risdate><volume>106</volume><spage>1537</spage><epage>1556</epage><pages>1537-1556</pages><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>•Cancer is an important public health problem globally.•HPV is responsible for 30% of all infectious agent-related cancer.•Oncoproteins (E6 and E7) cooperate to promote carcinogenesis.•Oncoproteins can lead to metabolic deregulation and metastasis.•Novel therapeutic and prophylactic vaccines are mandatory. Despite the novel diagnostic methods and therapies implemented in oncology, the number of patients that succumb by the cancer remains high globally. Currently studies point out that 20–25% of all human malignancies are related to micro-organism infections. Among these cancer-related pathogens, the human papillomavirus (HPV) has a prominent position, since the virus is responsible for about 30% of all infectious agent-related cancers. Thus, an amount of cancers could be avoided by means prophylactic and/or therapeutic measures. However, these measures required a holistic comprehension about HPV-related cancer biology. Based on this, this review aims to summarize the last evidences of HPV on cancer biology (from initiation to metastasis), focus on molecular and biochemical deregulations associated with viral infection, and discuss the viral etiology in different malignancies.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>30119229</pmid><doi>10.1016/j.biopha.2018.06.149</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2018-10, Vol.106, p.1537-1556
issn 0753-3322
1950-6007
language eng
recordid cdi_proquest_miscellaneous_2089856478
source MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Cancer progression
Cancer Vaccines - administration & dosage
Cell Transformation, Viral
Genotype
Host-Pathogen Interactions
HPV
Humans
Metastasis
Mutation
Neoplasms - metabolism
Neoplasms - pathology
Neoplasms - prevention & control
Neoplasms - virology
Oncogene Proteins, Viral - metabolism
Oncology
Papillomaviridae - genetics
Papillomaviridae - metabolism
Papillomaviridae - pathogenicity
Papillomavirus Infections - metabolism
Papillomavirus Infections - pathology
Papillomavirus Infections - prevention & control
Papillomavirus Infections - virology
Papillomavirus Vaccines - administration & dosage
Phenotype
Prognosis
Risk Factors
title The human papillomavirus (HPV)-related cancer biology: An overview
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A21%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20human%20papillomavirus%20(HPV)-related%20cancer%20biology:%20An%20overview&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Araldi,%20Rodrigo%20Pinheiro&rft.date=2018-10&rft.volume=106&rft.spage=1537&rft.epage=1556&rft.pages=1537-1556&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2018.06.149&rft_dat=%3Cproquest_cross%3E2089856478%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2089856478&rft_id=info:pmid/30119229&rft_els_id=S0753332218328178&rfr_iscdi=true